BCYC — Bicycle Therapeutics Share News
0.000.00%
Last trade - 00:00- $286.23m
- -$272.44m
- $72.59m
Bicycle Therapeutics PLC expected to post a loss of 68 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Curis, Sonos, Accolade, Shopify, Hoth Therapeutics
U.S. STOCKS ON THE MOVE-Curis Inc, Nvidia Corp, Veru Inc
Bicycle Therapeutics slumps after cancer therapy data update
Brief: Bicycle Therapeutics Reports FY Net Loss Of $66.8 Million
Bicycle Therapeutics PLC reports results for the quarter ended in September - Earnings Summary
Brief: Bicycle Therapeutics PLC Says QTRLY Loss Per Share $0.59
Brief: Bicycle Therapeutics Announces First Patient Dosed In Phase I/II Trial Of Bicycle Tumor-Targeted Immune Cell Agonist Bt7480
Brief: Bicycle Therapeutics Announces Publication Of Article Highlighting Preclinical Data From BT7480 Program
Bicycle Therapeutics PLC expected to post a loss of 61 cents a share - Earnings Preview
Brief: Bicycle Therapeutics PLC Announces Expansion Of Genentech Immuno-Oncology Collaboration
Bicycle Therapeutics slides on $125 mln share offering
Brief: Bicycle Therapeutics PLC Files For Offering Of Up To $125 Million Of Adss Representing Ordinary Shares
U.S. RESEARCH ROUNDUP-Hormel Foods, Omeros, Sirius XM Holdings
Brief: Bicycle Therapeutics Announces Interim BT5528 Phase I Trial Results, Prelim Results From BT8009 Phase I Clinical Trial
NASDAQ TRADE HALT HALT NEWS PENDING AT 12:45 PM
U.S. RESEARCH ROUNDUP -A O Smith, Cerence, Comerica
Brief: Bicycle Therapeutics To Present BT5528 Interim Phase I Data At AACR-NCI-EORTC Virtual International Conference On Molecular Targets And Cancer Therapeutics
Bicycle Therapeutics PLC reports results for the quarter ended in June - Earnings Summary